Stay updated with breaking news from Piramal agastya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prominent Indian scientist and industrialist Dr Swati Piramal has been conferred France’s top civilian honour for her contributions in the fields of business and industry, science, medicine, and towards strengthening Indo-French ties. Piramal, 66, is the vice-chairperson of the Mumbai-headquartered Piramal Group, a business conglomerate with interests in pharmaceuticals,
- Official Inauguration and Ribbon Cutting of New API Production Plant - Plant is part of the company's CAD $30 million capital investment in the site - New plant includes reactor suites
MUMBAI, India, July 7, 2022 /PRNewswire/ -- In our ongoing mission to bolster business insight and further augment organic growth and acquisition strategies, Piramal Pharma Ltd (PPL) today announced
The company made these announcements as part of its ongoing effort to strengthen its business presence in the Indian market and to further bolster its growth and acquisition strategies.
Brings 25 years of global operations and supply chain experience to PiramalExperience working with CDMOs and innovator/generic pharmaceutical companiesMulti-country track record of operational
- Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies - Increased focus on services
As per the Insurance Regulatory and Development Authority of India (Irdai) guidelines, a promoter cannot have a stake in more than one insurance company in the same segment.
Mumbai (Maharashtra) [India], February 14 (ANI/NewsVoir): Piramal Realty, the real estate arm of Piramal Group, announced the launch of its state-of-the-art Welltech homes at Piramal Aranya, Rani Baug, Byculla.
- Construction of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing and aseptic fill/finish facility in Grangemouth, Scotland and enhancement of existing Active Pharmaceutical